Active Ingredient(s): Amantadine
FDA Approved: * August 24, 2017
Pharm Company: * ADAMAS PHARMA LLC
Category: Parkinsons

Amantadine, sold under the brand name Gocovri among others, is a medication used to treat dyskinesia associated with parkinsonism and influenza caused by type A influenzavirus, though its use for the latter is no longer recommended due to widespread drug resistance.[5][6] It acts as a nicotinic antagonist, dopamine agonist, and noncompetitive NMDA antagonist.[7][8] The antiviral mechanism of action is antagonism of the influenzav... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Gocovri 68.5 mg Oral Capsule, Coated Pellets
NDC: 70482-085
Adamas Pharma, LLC
Gocovri 137 mg Oral Capsule, Coated Pellets
NDC: 70482-170
Adamas Pharma, LLC

Related Brands

Drugs with the same active ingredients